On 7 July 2022, ASLM’s LabCoP convened a session about the power of human papiloma virus (HPV) DNA testing in transforming cervical cancer screening in Africa: In this session, In this session, we highlight the value of screening with the HPV DNA test, and its clinical performance. We also share the Zambia country experience of adopting HPV DNA testing through the National Cancer Elimination Program, and insights on HIV/HPV diagnostics integration from the DREAM program in Mozambique. Please follow the links here to view the recorded ECHO session and download the presentation slides.